Amikacin Sulfate and Prochlorperazine Edisylate recalled due to sterility issues
by Press Release from Outbreak News Today on (#4G4NA)
East Brunswick, New Jersey company, Heritage Pharmaceuticals Inc. announced the recall of Amikacin Sulfate Injection, USP, 1g/4 mL (250mg/mL), Lot: VEAC025, Expiry Date: October 2019 and Prochlorperazine Edisylate Injection, USP, 10mg/2mL (5mg/mL), Lot: VPCA172, Expiry Date: April 2020, to the consumer level. The voluntary recall is being initiated due to microbial growth having been detected ["]
The post Amikacin Sulfate and Prochlorperazine Edisylate recalled due to sterility issues appeared first on Outbreak News Today.